Skip to content

Devyser HBOC NGS

Detect mutations in 12 important genes associated with hereditary breast and ovarian cancers (HBOC) in a single-tube, targeted-sequencing-test that delivers ready-to-be-sequenced libraries in just 5 hours.

5

Five hours from sample to sequencing

12

Sequence 12 genes relevant for breast and ovarian cancers

45

Less than 45 minutes of hands-on time

IVD

Single end-to-end CE-IVD solution

Flexible and versatile

Flexible and versatile

Devyser HBOC NGS can serve as a first-line protocol in parallel with BRCA1 and BRCA2 gene variant screening, adding 12 more genes to the process. It can also be used for follow-up after negative BRCA testing. The unique single-tube format dramatically speeds up the workflow, reducing lab handling time to less than 45 minutes.

End-to-end with fast results

The end-to-end test kit is easy to use, making it suitable for laboratories of any size. Minimize the risk of sample mix-up or cross-contamination thanks to included ID markers. Embedded data interpretation software ensures accurate analysis – and fast actionable results. The kit is purpose-designed to reduce laboratory processing costs by ensuring targeted sequencing with high uniformity and by maximizing sample capacity on every next-generation sequencing flow cell.

Value for at-risk relatives

The CE-IVD test kit is specifically designed to detect heritable germline mutations. This makes it a useful reference for clinical treatment and management decisions, as well as a valuable testing option for at-risk relatives. The included genes are ATM, PTEN, BARD1, RAD51C, RAD51D, BRIP1, CDH1, STK11, CHEK2, TP53, NBN and PALB2.

Downloads

Instructions for use

Enter access code found in the lower right corner of the label on the kit box.

product card

Certificates

Download a specific Batch Release Certificate (BRC) below.

Guidelines and handbooks (2)

Handbook Devyser HBOC EN 2020-02-13 (English)

pdf

Addendum to handbook Devyser VeritiPro NGS products 7-B902 v2023-03-31 (English)

99 kb pdf

Product information (3)

Flyer - Devyser HBOC for NGS (English)

pdf

PIB - Hereditary Cancer Testing (English)

pdf

IT Flyer - Devyser HBOC for NGS (Italian)

pdf

Software settings (4)

MiSeq IEM Files (English)

zip

Illumina double index (English)

pdf

Devyser HBOC Hg19 2019-08-26 (English)

bed

Devyser HBOC LRM files v2023-11-01 (English)

zip

Safety data sheets (1)

SDS Devyser NGS products 7-A428 v2024-08-13 (English)

486 kb pdf

Data tables (0)

Enter access code found in the lower right corner of the label on the kit box.

product card

Product details

CE-IVD

Devyser HBOC NGS

Sequence variants in 12 genes known to significantly increase the risk of developing breast and ovarian cancer in germline samples. They are ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53

8-A111-24

8-A111-48

Pack size: 24

Pack size: 48

RUO

Devyser HBOC NGS

Sequence variants in 12 genes known to significantly increase the risk of developing breast and ovarian cancer in germline samples. They are ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53

8-A111-24-RUO

8-A111-48-RUO

Pack size: 24

Pack size: 48

Ask us

Want to know more about Devyser HBOC NGS or do you have any questions?

Complete the form below and we will be in touch promptly.

smiling-staff-member

Data analysis made easy

Fast and effective test data analysis is crucial to achieving accurate outcomes and efficient workflows.

Dedicated software in our products makes analyzing test results quick, easy and trouble-free. For users, this means a streamlined end-to-end process with unmatched reliability and transparency.

Find out more

"
testimonial

Disclaimer: Products mentioned here are CE-IVD marked but not FDA-cleared. Availability in each country depends on local regulatory marketing authorization status. Please consult your local sales representative for details.